Insider trades
Edward J. Dulac III, CFO of Intellia Therapeutics NTLA, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $58.8K. The latest trade was on 03/01.
Edward J. Dulac III
EVP, CFO
- Company
- Intellia Therapeutics NTLA
- First filing
- 23/01/11
- Trades
- 18 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- −$58.8K
- Last trade
- 03/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 01/05 | 01/07 | 6,379 sh | $9.21 | $58,750.59 | −6.0% | |
| Open-market sale | 25/07/23 | 25/07/25 | 7,462 sh | $14.02 | $104,617.24 | −6.6% | |
| Open-market sale10b5-1 plan | 24/03/04 | 24/03/05 | 2,447 sh | $7.77 | $19,013.19 | −2.4% | |
| Open-market sale10b5-1 plan | 24/01/29 | 24/01/30 | 1,849 sh | $5.00 | $9,245 | −1.7% | |
| Open-market sale | 24/01/09 | 24/01/10 | 7,028 sh | $4.37 | $30,712.36 | −6.2% | |
| Open-market sale10b5-1 plan | 24/01/02 | 24/01/03 | 5,182 sh | $3.66 | $18,966.12 | −4.4% | |
| Open-market sale10b5-1 plan | 23/12/18 | 23/12/19 | 1,585 sh | $3.50 | $5,547.5 | −1.3% | |
| Open-market sale | 23/08/18 | 23/08/21 | 4,718 sh | $2.80 | $13,210.4 | −3.8% | |
| Open-market sale10b5-1 plan | 23/07/05 | 23/07/06 | 5,182 sh | $4.83 | $25,029.06 | −4.0% | |
| Open-market sale | 23/01/10 | 23/01/11 | 7,331 sh | $5.24 | $38,414.44 | −5.4% |
